Parol valuation, funding and investors
Parol works in AI-Powered medical documentation solutions, based in Bucharest, Romania. Founded in 2022, it has about 9 employees.
- Last round
- Seed · $1.26M · Dec 2024
- Valuation at last round
- $7.71M · implied
- Headcount
- 9 · down
- Grade
- C
- Founded
- 2022
Parol valuation today
VCMC values Parol at $6.14M today, with a range of $3.10M to $16.0M and a grade of C. The valuation starts from its last funding round, a seed round in Dec 2024.
Valuation by date (60 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2022 | $11.7M | $4.26M – $32.1M | $12.8M (+9%) | before first round | – | unknown | D | 0% |
| 1 Feb 2022 | $11.8M | $4.29M – $32.4M | $12.9M (+9%) | before first round | – | unknown | D | 0% |
| 1 Mar 2022 | $11.9M | $4.32M – $32.6M | $13.0M (+9%) | before first round | – | unknown | D | 0% |
| 1 Apr 2022 | $12.0M | $4.35M – $32.8M | $13.1M (+9%) | before first round | – | unknown | D | 0% |
| 1 May 2022 | $12.0M | $4.39M – $33.1M | $13.2M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jun 2022 | $12.1M | $4.42M – $33.3M | $13.3M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jul 2022 | $12.2M | $4.45M – $33.6M | $13.4M (+9%) | before first round | – | unknown | D | 0% |
| 1 Aug 2022 | $12.3M | $4.48M – $33.8M | $13.5M (+9%) | before first round | – | unknown | D | 0% |
| 1 Sep 2022 | $12.4M | $4.52M – $34.1M | $13.6M (+9%) | before first round | – | unknown | D | 0% |
| 1 Oct 2022 | $12.5M | $4.55M – $34.3M | $13.6M (+9%) | before first round | – | unknown | D | 0% |
| 1 Nov 2022 | $12.6M | $4.58M – $34.6M | $13.8M (+9%) | before first round | – | unknown | D | 0% |
| 1 Dec 2022 | $12.7M | $4.62M – $34.8M | $13.9M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jan 2023 | $10.2M | $3.72M – $28.1M | $11.2M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Feb 2023 | $10.3M | $3.75M – $28.3M | $11.2M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Mar 2023 | $10.4M | $3.78M – $28.5M | $11.3M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Apr 2023 | $10.4M | $3.80M – $28.7M | $11.4M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 May 2023 | $10.5M | $3.83M – $28.9M | $11.5M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Jun 2023 | $10.6M | $3.86M – $29.1M | $11.6M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Jul 2023 | $10.7M | $3.89M – $29.3M | $11.7M (+9%) | before first round | 4 | unknown | D | 0% |
| 1 Aug 2023 | $10.8M | $3.92M – $29.6M | $11.7M (+8%) | before first round | 4 | unknown | D | 0% |
| 1 Sep 2023 | $10.8M | $3.95M – $29.8M | $11.7M (+8%) | before first round | 4 | unknown | D | 0% |
| 1 Oct 2023 | $12.4M | $4.53M – $34.2M | $13.3M (+7%) | before first round | 9 | unknown | D | 0% |
| 1 Nov 2023 | $12.5M | $4.56M – $34.4M | $13.3M (+6%) | before first round | 9 | unknown | D | 0% |
| 1 Dec 2023 | $12.6M | $4.60M – $34.7M | $13.3M (+5%) | before first round | 9 | unknown | D | 0% |
| 1 Jan 2024 | $12.7M | $4.63M – $34.9M | $13.3M (+5%) | before first round | 9 | unknown | D | 0% |
| 1 Feb 2024 | $12.8M | $4.67M – $35.2M | $13.3M (+4%) | before first round | 9 | unknown | D | 0% |
| 1 Mar 2024 | $12.7M | $4.61M – $34.8M | $13.0M (+3%) | before first round | 8 | unknown | D | 0% |
| 1 Apr 2024 | $12.8M | $4.65M – $35.1M | $13.0M (+2%) | before first round | 8 | unknown | D | 0% |
| 1 May 2024 | $12.9M | $4.68M – $35.3M | $13.0M (+1%) | before first round | 8 | unknown | D | 0% |
| 1 Jun 2024 | $12.9M | $4.71M – $35.6M | $13.0M (+1%) | before first round | 8 | unknown | D | 0% |
| 1 Jul 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Aug 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Sep 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Oct 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Nov 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Dec 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 14 Dec 2024 | $7.72M | $5.06M – $23.5M | $15.4M (+100%) | after a round | 8 | unknown | C | 0% |
| 1 Jan 2025 | $7.99M | $5.06M – $23.5M | $15.4M (+93%) | after a round | 8 | unknown | C | 0% |
| 1 Feb 2025 | $8.47M | $5.06M – $23.5M | $15.4M (+82%) | after a round | 8 | unknown | C | 0% |
| 1 Mar 2025 | $8.94M | $5.06M – $23.5M | $15.4M (+72%) | after a round | 8 | unknown | C | 0% |
| 1 Apr 2025 | $9.48M | $5.06M – $23.5M | $15.4M (+63%) | after a round | 8 | unknown | C | 0% |
| 1 May 2025 | $10.0M | $5.06M – $23.5M | $15.4M (+54%) | after a round | 8 | unknown | C | 0% |
| 1 Jun 2025 | $10.6M | $5.06M – $23.5M | $15.4M (+45%) | after a round | 8 | unknown | C | 0% |
| 1 Jul 2025 | $11.3M | $5.06M – $23.5M | $15.4M (+37%) | after a round | 8 | unknown | C | 0% |
| 1 Aug 2025 | $12.5M | $5.43M – $25.2M | $16.5M (+32%) | after a round | 11 | growing | C | 0% |
| 1 Sep 2025 | $13.3M | $5.43M – $25.2M | $16.5M (+24%) | after a round | 11 | growing | C | 0% |
| 1 Oct 2025 | $14.2M | $5.43M – $25.2M | $16.5M (+17%) | after a round | 11 | growing | C | 0% |
| 1 Nov 2025 | $15.1M | $5.43M – $25.2M | $16.5M (+9%) | after a round | 11 | growing | C | 0% |
| 1 Dec 2025 | $16.1M | $5.43M – $25.2M | $16.5M (+3%) | after a round | 11 | growing | C | 0% |
| 1 Jan 2026 | $16.5M | $5.45M – $25.2M | $16.5M (0%) | after a round | 11 | growing | C | 0% |
| 1 Feb 2026 | $16.5M | $5.47M – $25.2M | $16.5M (0%) | after a round | 11 | growing | C | 0% |
| 1 Mar 2026 | $16.2M | $4.93M – $24.6M | $16.2M (0%) | after a round | 10 | up | C | 0% |
| 1 Apr 2026 | $15.8M | $4.67M – $24.1M | $15.8M (0%) | after a round | 9 | up | C | 0% |
| 1 May 2026 | $15.8M | $4.54M – $24.1M | $15.8M (0%) | after a round | 9 | up | C | 0% |
| 1 Jun 2026 | $8.27M | $4.02M – $16.0M | $5.72M (-31%) | after a round | 10 | flat | C | 79% |
| 1 Jul 2026 | $8.10M | $3.83M – $16.3M | $5.56M (-31%) | after a round | 10 | flat | C | 79% |
| 1 Aug 2026 | $7.92M | $3.64M – $16.7M | $5.41M (-32%) | after a round | 10 | flat | C | 79% |
| 1 Sep 2026 | $7.75M | $3.46M – $17.0M | $5.26M (-32%) | after a round | 10 | flat | C | 79% |
| 1 Oct 2026 | $6.26M | $3.22M – $15.7M | $3.87M (-38%) | after a round | 9 | down | C | 97% |
| 24 Oct 2026 | $6.14M | $3.10M – $16.0M | $3.77M (-39%) | after a round | 9 | down | C | 97% |
Key facts about Parol
- Founded
- 2022
- Headquarters
- Bucharest, Romania
- Employees
- about 9 -18% in a year
- Total raised
- $1.3M
- Funding rounds
- 1
- Last round
- Seed Dec 2024
Parol funding history
Parol has 1 funding round on record, from Dec 2024 to Dec 2024, $1.3M in total. None disclosed a valuation.
Seed 13 Dec 2024
Led by GapMinder.
$1.3M
Parol investors
1 investor has backed Parol; GapMinder led at least one round.
What Parol does
Parol works in tech companies, with 13 recorded offerings and customers in healthcare.
Dikta Inc S.R.L., known as Parol, is a Romanian company engaged in health technology, focusing on AI-powered medical documentation solutions. The company develops and operates a platform that automates clinical documentation by converting doctor-patient conversations into structured medical notes, and integrates with electronic health record systems in Europe and the United States. Parol serves healthcare providers across various specialties and offers features such as ambient AI listening, instant medical reports, and EHR integration. The company is certified for data protection and privacy.
Description from Veridion's company data.
Products and services
- AI-Powered Medical Documentation Solutions
- Ambient AI Medical Scribe Services
- Clinical Documentation Automation
- Clinical Note Generation and Structuring
- EHR Integration and Data Exchange
- Clinical Note Exporting for EHR Systems
- Multilingual Medical Documentation Services
- Specialty-Specific Clinical Documentation Services
- HIPAA-Compliant Medical Documentation Services
- Clinical Documentation Consistency Improvement
- Patient Care Optimization Services
- Healthcare Administrative Burden Reduction
- Clinical Documentation Demo Services
Markets
- Healthcare
Technology
- Ambient AI Listening
Certifications
- HIPAA compliant
Business model
- Business-to-Business
- Software-as-a-Service
- Subscription-Based
Industry codes (NAICS)
- 513210 Software Publishers 100% match
Questions about Parol
What is Parol worth?
Valuation $6.14M (range $3.10M to $16.0M), as of 24 Oct 2026.
Has Parol raised money?
Parol has 1 funding round on record, from Dec 2024 to Dec 2024, $1.3M in total. None disclosed a valuation.
Who has invested in Parol?
GapMinder. Lead investors include GapMinder.
How many people work at Parol?
About 9, down 18% over the last year. Headcount rose from 4 in Jan 2023 to 11 in Aug 2025, then fell to 9 in Sep 2026.
What does Parol do?
Parol works in tech companies, with 13 recorded offerings and customers in healthcare. Its main offerings are AI-Powered medical documentation solutions, ambient AI medical scribe services and clinical documentation automation.
When was Parol founded, and where is it based?
Parol was founded in 2022 and is based in Bucharest, Romania. It has about 9 employees, down 18% over the last year.